American Regent has recalled three lots of Epinephrine Injection, USP, after leaking and cracked vials were found to contain particulate matter. The nationwide recall covers three lots of the 30 milligram/30 milliliter product, according to a Sept. 3 FDA news…

AstraZeneca’s tozorakimab is the first biologic to demonstrate statistically significant efficacy in reducing moderate and severe COPD exacerbations in a broad population of patients who continued to experience exacerbations while receiving inhaled standard-of-care therapy. Tozorakimab reduced moderate and severe COPD…

The FDA has granted accelerated approval to Etcamah (camizestrant), marking the first FDA approval of a cancer therapy guided by the detection of a resistance mutation in circulating tumor DNA before imaging tests show disease progression. Etcamah is used with…

The FDA has approved Zanvastro (zilganersen) injection to treat Alexander disease in pediatric and adult patients, making it the first FDA-approved treatment for the rare neurological disease. Zanvastro is also the first therapy to directly target the protein buildup that…

Medication safety has drawn renewed national scrutiny after Ascension St. Thomas Hospital Midtown in Nashville, Tenn., confirmed that four joint replacement patients were mistakenly injected with potassium phosphate instead of the anesthetic mepivacaine Aug. 14.  A state survey later found…

An oral targeted therapy approved for pancreatic cancer showed antitumor activity in previously treated lung cancer, according to early-phase data published Sept. 2 in The New England Journal of Medicine. The drug, Rasonque (daraxonrasib), is an oral RAS inhibitor from…

The FDA has announced a request for information to gather public input on ways to advance the development of botanical drug products, according to a Sept. 3 agency news release. Botanical drug products are derived from plant materials, algae or…

On Aug. 26, the FDA approved daraxonrasib, brand name Rasonque, for adults with advanced pancreatic cancer that has stopped responding to chemotherapy. The approval came three months after a landmark study found the drug extended progression-free survival by a median…

The 5th U.S. Circuit Court of Appeals affirmed Aug. 27 that the FDA acted lawfully when it declared Eli Lilly’s tirzepatide shortage resolved, according to court documents reviewed by Becker’s The ruling delivers a defeat to compounding pharmacies that had…

Hartford, Conn.-based Saint Francis Hospital has launched a program offering free prescription medications to uninsured, low-income patients with chronic illnesses. The program, launched through a partnership with Dispensary of Hope, provides medications through the Saint Francis Rx Pharmacy, according to…